相关实验视频

Updated: Feb 28, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

卢米实验室:一个基础模型驱动的自主平台,可以发现用于mRNA输送的电离性脂质设计

Yue Xu¹, Haotian Cui², Kuan Pang³

¹Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.

|February 26, 2026

概括

由人工智能驱动的机器人平台LUMI-lab加速了分子发现,识别了新的脂质纳米粒子 (LNP),以提高mRNA传递. 这种自动驾驶系统克服了数据稀缺性,以实现高效的RNA技术开发.

科学领域:

生物技术是生物技术.
人工智能的人工智能
机器人技术机器人技术机器人技术

背景情况:

人工智能和机器人整合加速了分子发现,但在新兴领域面临着数据稀缺的挑战.
有效地探索化学空间对于开发新疗法至关重要.

研究的目的:

介绍LUMI-lab,一个使用人工智能和主动学习的自动驾驶平台,以解决分子发现中的数据稀缺问题.
展示LUMI-lab在自主合成和选脂质纳米粒子 (LNPs) 进行mRNA输送方面的能力.

主要方法:

集成了一个基于变压器的基础模型与一个主动学习实验工作流.
自主合成和选超过1700个脂质纳米粒子 (LNPs).
利用人工智能驱动的机器人系统进行数据高效分子优化.

主要成果:

在人类支气管细胞中鉴定出具有增强mRNA转染功能的电离性脂质.
发现化脂尾作为改善mRNA递送的关键特征.
在使用LUMI-6 LNP的小鼠肺上皮细胞中实现了20.3%的基因编辑疗效.

结论:

卢米实验室是一个强大的,数据效率高的平台,用于自主分子发现和优化.
人工智能驱动的机器人系统在推进下一代RNA传递技术方面具有重大潜力.
证明了人工智能的有效性,加速了新型治疗输送系统的发现.

关键词:

药物输送是药物输送的过程.基础模型的基础模型.脂质纳米颗粒的使用方法机器学习是机器学习.自动驾驶实验室自动驾驶实验室

更多相关视频

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

相关概念视频

Fluid Mosaic Model

Fluid Mosaic Model

Scientists identified the plasma membrane in the 1890s and its principal chemical components (lipids and proteins) by 1915. The model for plasma membrane structure, proposed in 1935 by Hugh Davson and James Danielli, was the first model to be widely accepted in the scientific community. The model was based on the plasma membrane's "railroad track" appearance in early electron micrographs. Davson and Danielli theorized that the plasma membrane's structure resembled a sandwich...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.